Abstract
ObjectiveTo alleviate the economic burden of innovative drugs on patients in China, the government has been negotiating drug prices since 2016 to enhance their accessibility. This systematic review aimed to...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have